I’m thrilled to welcome Christina back to the show for a second time. The world has changed since we last spoke and much of the cannabis research she was doing has been forced aside by COVID-19. We tackle that issue along with raising a child that uses medical cannabis, how cortisol affects cannabis efficacy, and the future of customized cannabis medicine.

Check out Christina's companies and organizations:

Affinity Patient Advocacy

• Web - https://www.affinitypatientadvocacy.org
• Instagram - @advocacypatient
• LinkedIn - https://www.linkedin.com/company/affinity-patient-advocacy/
• Facebook - @affinitypatientadvocacy
• Twitter - @AdvocAffinity

Affinity Bio Partners

• Web - https://www.affinitybiopartners.com
• Instagram - @affinitybiopartners
• LinkedIn - https://www.linkedin.com/company/armonia-clinical-research-llc/
• Facebook - @affinitybiogroup
• Twitter - @AffinityBioP

AI Health Outcomes

• Instagram - @cannabot
• LinkedIn - https://www.linkedin.com/company/ai-health-outcomes/
• Facebook - @AIHealthOutcomes
• Twitter - @BotCanna

This Edge of Cannabis Medicine Podcast is Copyright EM2P2, Inc., 2020. All rights reserved. Podcast use and availability is governed by terms and disclaimers available at https://edgeofcannabismedicine.com/terms

Find out more at http://edgeofcannabismedicine.com